Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab
Clinical trial NCT03472885 · COMPLETED
Trial details
- NCT number
- NCT03472885
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-08
- Primary completion
- 2019-09-20
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.